Anti-SYNC monoclonal antibody

Pre-made anti-SYNC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYNC/SYNC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2763-Ab-1/ GM-Tg-hg-IP2763-Ab-2Anti-Human SYNC monoclonal antibodyHuman
GM-Tg-rg-IP2763-Ab-1/ GM-Tg-rg-IP2763-Ab-2Anti-Rat SYNC monoclonal antibodyRat
GM-Tg-mg-IP2763-Ab-1/ GM-Tg-mg-IP2763-Ab-2Anti-Mouse SYNC monoclonal antibodyMouse
GM-Tg-cynog-IP2763-Ab-1/ GM-Tg-cynog-IP2763-Ab-2Anti-Cynomolgus/ Rhesus macaque SYNC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2763-Ab-1/ GM-Tg-felg-IP2763-Ab-2Anti-Feline SYNC monoclonal antibodyFeline
GM-Tg-cang-IP2763-Ab-1/ GM-Tg-cang-IP2763-Ab-2Anti-Canine SYNC monoclonal antibodyCanine
GM-Tg-bovg-IP2763-Ab-1/ GM-Tg-bovg-IP2763-Ab-2Anti-Bovine SYNC monoclonal antibodyBovine
GM-Tg-equg-IP2763-Ab-1/ GM-Tg-equg-IP2763-Ab-2Anti-Equine SYNC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2763-Ab-1/ GM-Tg-hg-IP2763-Ab-2; GM-Tg-rg-IP2763-Ab-1/ GM-Tg-rg-IP2763-Ab-2;
GM-Tg-mg-IP2763-Ab-1/ GM-Tg-mg-IP2763-Ab-2; GM-Tg-cynog-IP2763-Ab-1/ GM-Tg-cynog-IP2763-Ab-2;
GM-Tg-felg-IP2763-Ab-1/ GM-Tg-felg-IP2763-Ab-2; GM-Tg-cang-IP2763-Ab-1/ GM-Tg-cang-IP2763-Ab-2;
GM-Tg-bovg-IP2763-Ab-1/ GM-Tg-bovg-IP2763-Ab-2; GM-Tg-equg-IP2763-Ab-1/ GM-Tg-equg-IP2763-Ab-2
Products NameAnti-SYNC monoclonal antibody
Formatmab
Target NameSYNC
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYNC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2763-Ag-1Recombinant multi-species SYNCI/ SYNC/ SYNC1OILIN protein


    Target information

    Target IDGM-IP2763
    Target NameSYNC
    Gene ID81493,68828,362606,709783,487303,101082504,618122,100070162
    Gene Symbol and Synonyms1110057H03Rik,SNIP4,SYNC,SYNC1,SYNCOILIN
    Uniprot AccessionQ9H7C4
    Uniprot Entry NameSYNCI_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162520
    Target ClassificationN/A

    The target: SYNC, gene name: SYNC, also named as SYNC1OILIN, SYNC. This gene encodes a member of the intermediate filament family which contains an N-terminal head domain, followed by a central coiled-coil region and a short C-terminal tail. The protein is highly expressed in skeletal and cardiac muscle. The protein links the dystrophin associated protein complex (DAPC) to desmin filaments in muscle and may have a structural role in striated muscle. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.